APA (7th ed.) Citation

JY, K., XJ, Z., WD, Y., ZW, Y., FL, F., GW, D., . . . SL, C. (2026). Ambrisentan for Early-Stage Low-Risk Pulmonary Arterial Hypertension: Design of the Randomized, Double-Blind, Placebo-Controlled ALEPH Trial. JACC. Asia, 6(5), 724. https://doi.org/10.1016/j.jacasi.2025.12.014

Chicago Style (17th ed.) Citation

JY, Kan, et al. "Ambrisentan for Early-Stage Low-Risk Pulmonary Arterial Hypertension: Design of the Randomized, Double-Blind, Placebo-Controlled ALEPH Trial." JACC. Asia 6, no. 5 (2026): 724. https://doi.org/10.1016/j.jacasi.2025.12.014.

MLA (9th ed.) Citation

JY, Kan, et al. "Ambrisentan for Early-Stage Low-Risk Pulmonary Arterial Hypertension: Design of the Randomized, Double-Blind, Placebo-Controlled ALEPH Trial." JACC. Asia, vol. 6, no. 5, 2026, p. 724, https://doi.org/10.1016/j.jacasi.2025.12.014.